Alex L Laursen
Overview
Explore the profile of Alex L Laursen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
244
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Honge B, Andersen M, Petersen M, Jespersen S, Medina C, Te D, et al.
AIDS
. 2023 Jul;
37(12):1773-1781.
PMID: 37475710
Objective: AIDS-defining illness develops at higher CD4 + T-cell counts in individuals infected with HIV-2 compared with HIV-1-infected, which suggests that the two types of HIV may have different effects...
2.
Bollerup S, Engsig F, Hallager S, Mocroft A, Roege B, Christensen P, et al.
J Hepatocell Carcinoma
. 2022 Oct;
9:1093-1104.
PMID: 36281336
Purpose: We aimed to determine incidence of hepatocellular carcinoma (HCC) and decompensated liver cirrhosis in persons with chronic hepatitis B virus (HBV) infection in Denmark stratified by disease phase, liver...
3.
Bollerup S, Hallager S, Engsig F, Mocroft A, Krarup H, Madsen L, et al.
J Viral Hepat
. 2022 May;
29(9):727-736.
PMID: 35633092
The study aimed to determine adjusted all-cause mortality and cause of death in persons with chronic hepatitis B virus (HBV) infection compared with age- and sex-matched persons from the general...
4.
Fahnoe U, Pedersen M, Solund C, Ernst A, Krarup H, Roge B, et al.
J Viral Hepat
. 2020 Nov;
28(2):302-316.
PMID: 33131178
Direct-acting antivirals (DAAs) have proven highly effective against chronic hepatitis C virus (HCV) infection. However, some patients experience treatment failure, associated with resistance-associated substitutions (RASs). Our aim was to investigate...
5.
Ingvorsen E, Schnohr C, Andersen T, Lehrmann L, Funding E, Poulsen L, et al.
BMC Public Health
. 2019 Dec;
19(1):1714.
PMID: 31856778
Background: Between 1975 and 1985 a total of 91 Danish patients with moderate and severe hemophilia (PWH) was infected with HIV constituting a major scandal in the Danish health care...
6.
Madsen T, Jespersen S, Medina C, Te D, Wejse C, Laursen A, et al.
AIDS Behav
. 2019 Nov;
24(5):1476-1485.
PMID: 31705346
As partner notification (PN) has shown effective in increasing the number of partners of HIV infected patients being tested we aimed to evaluate the feasibility of implementing PN in the...
7.
Honge B, Petersen M, Jespersen S, Medina C, Te D, Kjerulff B, et al.
AIDS
. 2019 Mar;
33(7):1131-1141.
PMID: 30845070
Background: For unknown reasons, HIV-2 is less pathogenic than HIV-1, and HIV-2-induced immunodeficiency may be different from that caused by HIV-1. Previous immunological studies have hinted at possible shifts in...
8.
Honge B, Petersen M, Jespersen S, Medina C, Te D, Kjerulff B, et al.
AIDS
. 2019 Mar;
33(7):1143-1153.
PMID: 30845069
Background: HIV-2 may slow progression of a subsequently acquired HIV-1 infection through cross-neutralizing antibodies and polyfunctional CD8 T cells. We hypothesized that HIV-1/2 dually infected patients compared with HIV-1-infected patients...
9.
Solund C, Andersen E, Mossner B, Laursen A, Roge B, Kjaer M, et al.
Eur J Gastroenterol Hepatol
. 2018 Jul;
30(10):1177-1186.
PMID: 29994874
Objective: New potent direct-acting antiviral (DAA) regimens against hepatitis C virus have been approved in recent years. However, information about the rate of adverse events (AEs) across different DAA regimens...
10.
Solund C, Hallager S, Pedersen M, Fahnoe U, Ernst A, Krarup H, et al.
Scand J Gastroenterol
. 2018 May;
53(7):849-856.
PMID: 29720023
Objectives: We describe factors associated with and barriers to initiation of Direct Acting Antiviral (DAA) treatment in patients with chronic hepatitis C, who fulfill national fibrosis treatment guidelines in Denmark....